Trusted Resources: News & Meetings
Latest announcements and gatherings
International Symposium on Graves’ Orbitopathy
The EUGOGO 20th Anniversary Meeting programme will be submitted for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME) and the Italian Educazione Continua in medicine (ECM) for Physician (Medico Chirurgo).
Certificate of Attendance can be collected at registration desk only at the end of the Meeting.
When:
November 7- 9, 2019
Where:
Camera di Commercio di Pisa
Piazza Vittorio Emanuele II, 5-56125
Pisa, Italy.
The event has ended.
myBinderRelated Content
-
Breakthrough Treatment for Thyroid Eye DiseaseFor those with severe inflammation from ...
-
Radiotherapy for Active Thyroid Eye DiseasePurpose: To critically review the publi...
-
Teprotumumab Improves Short and Long-Term Clinical Outcomes in Thyroid Eye DiseaseMost adults with thyroid eye disease rec...
-
Mycophenolate Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-Severe Graves’ Or...Background: European guidelines recomme...
-
Manejo Quirúrgico de la Enfermedad de Graves• La tiroidectomía puede considerarse...
-
Total Thyroidectomy (Tx) Versus Thionamides (Antithyroid Drugs) in Patients With Moderate-to-Severe Graves’ Op...Background: Graves' disease (GD) is cha...
-
The Medical University of South Carolina Health Graves’ Eye Disease ClinicThe Medical University of South Carolina...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google